Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 65

Results For "RAT"

6702 News Found

Novartis Tafinlar and Mekinist demonstrates unprecedented efficacy in pediatric patients
News | June 08, 2022

Novartis Tafinlar and Mekinist demonstrates unprecedented efficacy in pediatric patients

If approved, Tafinlar + Mekinist may offer a potential new standard-of-care for pediatric patients with this brain cancer


NHA organizes orientation workshop on Ayushman Bharat Digital Mission in Mumbai
Policy | June 08, 2022

NHA organizes orientation workshop on Ayushman Bharat Digital Mission in Mumbai

The second phase of the orientation workshop is being organized to provide in-depth knowledge to the state officials on core building blocks of ABDM


CerTest Biotec and BD collaborates for molecular diagnostic test for Monkeypox
Diagnostic Center | June 08, 2022

CerTest Biotec and BD collaborates for molecular diagnostic test for Monkeypox

CerTest Biotec uses the BD MAX molecular diagnostic system open system reagent suite to develop RT-PCR detection kit


Thermo Fisher Scientific collaborates with TransMIT to promote MSI platform
News | June 07, 2022

Thermo Fisher Scientific collaborates with TransMIT to promote MSI platform

Co-marketing agreement between Thermo Fisher Scientific and TransMIT allows for high spatial and high mass resolution MSI platform to study complex biological tissues


ANI Pharmaceuticals consolidates operation post Novitium acquisition
News | June 06, 2022

ANI Pharmaceuticals consolidates operation post Novitium acquisition

Operations at Oakville, Canada manufacturing plant expected to end by first quarter 2023


Proxygen and Merck collaborates to develop molecular glue degraders
News | June 06, 2022

Proxygen and Merck collaborates to develop molecular glue degraders

The companies will jointly identify and develop molecular glue degraders up to a clinical candidate stage.


Merck’s pembrolizumab demonstrates improvement in distant metastasis
News | June 06, 2022

Merck’s pembrolizumab demonstrates improvement in distant metastasis

Immune-mediated events and infusion reactions were higher with KEYTRUDA (38% vs 9%, respectively).


Organon introduces global ESG strategy
Sustainability | June 04, 2022

Organon introduces global ESG strategy

Report lays out blueprint for achieving Organon’s purpose and business imperatives to help women and girls achieve their promise through better health


Vial to launch oncology CRO, Arati Rao named as First Advisor
News | June 02, 2022

Vial to launch oncology CRO, Arati Rao named as First Advisor

The new Oncology CRO will aim to drive faster execution and higher quality trial outcomes for Oncology sponsors.